General Biologicals (ROCO:4117) LT-Debt-to-Total-Asset : 0.62 (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is General Biologicals LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. General Biologicals's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.62.

General Biologicals's long-term debt to total assets ratio increased from Dec. 2023 (0.15) to Dec. 2024 (0.62). It may suggest that General Biologicals is progressively becoming more dependent on debt to grow their business.

General Biologicals LT-Debt-to-Total-Asset Historical Data

The historical data trend for General Biologicals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

General Biologicals LT-Debt-to-Total-Asset Chart

General Biologicals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.35

0.29

0.15

0.62

General Biologicals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.29	0.22	0.15	0.54	0.62

General Biologicals LT-Debt-to-Total-Asset Calculation

General Biologicals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	2100.929	/	3405.718
	=	0.62

General Biologicals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	2100.929	/	3405.718
	=	0.62

General Biologicals (ROCO:4117) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

General Biologicals LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of General Biologicals's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

General Biologicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » General Biologicals Corp (ROCO:4117) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No-6, Innovation First Road, Hsinchu Science Park, Hsinchu, TWN, 300092

Website

https://www.gbc.com.tw

General Biologicals Corp is a developer and manufacturer of vitro diagnostic devices in Taiwan. It offers research development, marketing and servicing of products and solutions for hospitals, medical laboratories, blood banks, and research and industry. Its products include Anti-HDV, HIV Ag-Ab COMB, Anti-HBs, and many others.

General Biologicals Headlines

No Headlines